DALI // EU Project

Project description:

Europe is facing a rapidly growing threat from Type 2 diabetes mellitus (T2D), which is undoubtedly associated with an unhealthy diet and a more sedentary lifestyle. Evidence is accumulating that gestational diabetes mellitus (GDM) may be playing a role in this process. Thus it provides a significant opportunity for preventing future T2D. Not only is GDM prevalence on the rise, but intrauterine exposure to hyperglycaemia predisposes the offspring to diabetes and obesity. Another putative contributing factor is a low vitamin D status, which is also increasing in prevalence and may have causal links with both obesity and decreased glucose tolerance. The main aims of the DALI project are: 1) to establish the current status of the prevalence of GDM in Europe and facilitate the adoption of a single diagnostic approach and 2) to deliver the best strategy for preventing GDM. The latter was deemed to be not fully feasible within the scope of this call and our decision was to test the most relevant approaches (diet, exercise, vitamin D, alone or in combination) against surrogate variables of GDM (fasting blood glucose, insulin sensitivity, pregnancy weight gain) to come up with the best intervention for entry into a definitive GDM prevention trial. Deliverables include the sample size and modus operandi for such a trial. Value will be added to DALI by 1) Assessing variables that modify the uptake of preventive interventions, 2) Exploring the health costs of GDM and potential savings of preventive approaches, 3) Improving pathophysiological understanding by assessing the intervention effect on several parameters in mother and foetus and 4) Facilitating future research through a well defined cohort of mother-offspring pairs and comprehensive biobanking.

© Medical University of Graz

Quick overview:

Programme: FP7-HEALTH
Project Reference: 242187
Coordinator: Medical University of Graz, Austria
Status: Execution
Start: 01.03.2010
End: 31.12.2015
Total Cost: EUR 3,862,867.47
EU contribution: EUR 2,999,429


biolution contribution:

Proposal preparation: Content, Administration, Logo
Grant preparation: Contact point, Contract development, Budget

© Medical University of Graz

Partners / Collaborations

Medical University of Graz, AT
Medical University of Vienna, AT
Catholic University of Leuven, BE
Odense University Hospital, DN
Region Hovedstaden, DN
HUS – The Hospital District of Helsinki and Uusimaa, FI
National University of Ireland, Galway, IE
University of Padova, IT
Stichting VU-VUMC, NL
VU University Amsterdam, NL
Poznan University of Medical Sciences, PL
BAP Health Outcomes Research SL, ES
Research Institute of the Sant Pau Hospital, ES
Recherche en Santé Lawson SA, CH
Cambridge University Hospitals NHS Foundation Trust, UK
Medical Research Council, UK
Consulting Diabetes EU Projects FP7 Nutrition

Related items: